• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

Research & Development

Delpor wins $1.5m NIH grant for diabetes drug implant

June 14, 2017 By Sarah Faulkner

Delpor

Delpor Inc. said today that it won a $1.5 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases to support the development of its exenatide implant. The implant was designed for patients with Type II diabetes and features Delpor’s Nanopor technology, which uses passive diffusion to deliver therapeutic levels of exenatide […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, Funding Roundup, Implants, Pharmaceuticals, Research & Development Tagged With: delpor, National Institutes of Health

This microhole chip identifies and sorts cancer cells

June 12, 2017 By Danielle Kirsh

microhole chip

Fraunhofer researchers have created a microhole chip that can identify and characterize cancer cells within minutes – helping to catch metastasis before it can begin. Traditional fluorescence-activated cell sorting (FACS) gives an estimate of the number of tumor cells in a patient’s bloodstream. If there is a higher concentration of tumor cells, there is a […]

Filed Under: Diagnostics, Featured, Research & Development Tagged With: Cancer, fraunhofer, medtech, metastatic cancer, microhole chip, tumor cells

Nanoparticles use 2 mechanisms to boost immunotherapy

June 12, 2017 By Sarah Faulkner

Nanoparticle immunotherapy

Cancer immunotherapy, a treatment approach that has gained momentum over the past few years, only helps a small fraction of patients. But researchers from the Johns Hopkins University School of Medicine have developed a nanoparticle that may one day help expand the patient population that benefits from immunotherapy. Immunotherapy usually falls into 1 of 2 […]

Filed Under: Featured, Immunotherapy, Nanoparticles, Oncology, Preclinical Trials, Research & Development Tagged With: Johns Hopkins

This bacterial discovery could prevent biofilms

June 9, 2017 By Danielle Kirsh

Researchers at the University of Texas at Austin have discovered a potential new way to eliminate biofilms to reduce the number of hospital-borne infections. Biofilms are a group of microorganisms that stick to a surface. Over time, the cells in the biofilm can grow and cause chronic infections and can even become resistant to antibiotics. […]

Filed Under: Featured, Research & Development, Wound Care Tagged With: bacteria, biofilm, infections, University of Texas at Austin

Medtech stories we missed this week: June 9, 2017

June 9, 2017 By Danielle Kirsh

missed medtech

From 3M’s expanded 510(k) clearance for its Tegaderm dressing to Medtronic and Acacia burying the hatchet, here are 7 medtech stories we missed this week but thought were still worth mentioning. 1. InspireMD inks Taiwanese distro deal for CGuard InspireMD announced in a June 8 press release that it has signed a distribution deal with […]

Filed Under: Business/Financial News, Clinical Trials, Featured, Food & Drug Administration (FDA), Regulatory/Compliance, Research & Development Tagged With: 3M, Acacia Research Corp., Active Implants, Advanced Cooling Therapy, Attune Medical, Exactech Inc., HLT, InspireMD, medtech, Medtronic

Magnets, nanoparticles open and close blood vessels for targeted drug delivery

June 9, 2017 By Sarah Faulkner

Magnets for targeted drug delivery - Rice University team

Tightly-packed endothelial cells line blood vessels and maintain a highly structured barrier. But researchers from Rice University, Emory University and the Georgia Institute of Technology have found a way to selectively create “leaky” blood vessels for targeted drug delivery. The team’s study, which was published in Nature Communications, reported that magnets can help lead iron-oxide nanoparticles […]

Filed Under: Drug-Device Combinations, Featured, Nanoparticles, Pharmaceuticals, Research & Development Tagged With: emoryuniversity, Georgia Institute of Technology, Rice University

Ascensia Diabetes Care inks integration deal with Insulet

June 8, 2017 By Fink Densford

Ascensia Diabetes Care, Insulet Corp

Ascensia Diabetes Care said today it inked a strategic alliance with Insulet (NSDQ:PODD) to integrate connectivity between Insulet’s next-gen Omnipod system with Ascensia’s Contour Next One blood glucose monitoring system. Through the deal, Parsippany, N.J.-based Ascensia’s Contour Next will be designed to pair via Bluetooth with the Omnipod Dash personal diabetes manager to automatically communicate blood glucose […]

Filed Under: Business/Financial News, Diabetes, Research & Development Tagged With: Ascensia Diabetes Care, Insulet

Biopolymer tested as long-acting glucose control therapy

June 6, 2017 By Sarah Faulkner

Researchers from Duke University have developed a biopolymer that could provide weeks of glucose control for patients with diabetes – in a single injection. The controlled-release treatment lasted for weeks in primates, according to a study published in Nature Biomedical Engineering. The biomedical engineers suggested that this new, injectable solution could replace daily or weekly insulin shots for […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, Preclinical Trials, Research & Development Tagged With: Duke University

Hydrogel tech boosts success of transplanted insulin-producing cells

June 5, 2017 By Sarah Faulkner

Hydrogel w/ pancreatic islet cells

A hydrogel material embedded with a protein to improve blood vessel growth may boost the success rate of transplanting insulin-producing islet cells into patients with Type I diabetes, according to a preclinical study published in the journal Science Advances.  In the newly-published work, supported by the National Institutes of Health and the Juvenile Diabetes Research Foundation, […]

Filed Under: Diabetes, Featured, Preclinical Trials, Research & Development Tagged With: Georgia Institute of Technology

Medtech stories we missed this week: June 2, 2017

June 2, 2017 By Danielle Kirsh

From Implandata receiving CE Marking to Inolife eyeing up-listing, here are 7 medtech stories we missed this week but thought were still worth mentioning. 1. Dextera seeks expanded indications for MicroCutter 5/80 stapler Dextera Surgical announced in a June 1 press release that it has filed a 510(k) with the FDA for its MicroCutter 5/80 stapler. The […]

Filed Under: Clinical Trials, Diabetes, Featured, Food & Drug Administration (FDA), Regulatory/Compliance, Research & Development Tagged With: c2 Therapeutics, Dextera Surgical, DreaMed Diabetes, EndoGastric Solutions Inc., Implandata, Inolife, medtech, MicroTransponder Inc.

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 24
  • Page 25
  • Page 26
  • Page 27
  • Page 28
  • Interim pages omitted …
  • Page 48
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS